Effects of Transcranial Photobiomodulation in ADHD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-44
SponsorFrancisco Gonzalez-Lima, PhD

About this trial

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM).

The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Eligibility criteria

Qualifiers

English-speaking

Adults of any sex

Age range: 18-44 years

Any ethnic/racial background

Disqualifiers

Currently pregnancy

Any sham or active photobiomodulation treatment within the past five weeks.

Trial design

Treatments tested in this trial

  • Active transcranial photobiomodulation
  • Sham transcranial photobiomodulation

Treatment groups

140 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Francisco Gonzalez-Lima, PhD

Lead sponsor

University of Texas at Austin

Sponsor institution